Loeffler endocarditis
diseaseOn this page
Also known as eosinophilic endocarditiseosinophilic endomyocardial disease
Summary
Loeffler endocarditis (MONDO:0019159) is a disease. A subtype of non-familial restrictive cardiomyopathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: Unknown (Worldwide)
- Phenotypes (HPO): 27
Clinical features
Signs & symptoms
Clinical features (HPO)
27 HPO clinical features (Orphanet curated; top 27 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0001723 | Restrictive cardiomyopathy | Very frequent (80-99%) |
| HP:0001880 | Eosinophilia | Very frequent (80-99%) |
| HP:0001977 | Abnormal thrombosis | Very frequent (80-99%) |
| HP:0031323 | Myocardial eosinophilic infiltration | Very frequent (80-99%) |
| HP:0001635 | Congestive heart failure | Frequent (30-79%) |
| HP:0001654 | Abnormal heart valve morphology | Frequent (30-79%) |
| HP:0001712 | Left ventricular hypertrophy | Frequent (30-79%) |
| HP:0001824 | Weight loss | Frequent (30-79%) |
| HP:0001962 | Palpitations | Frequent (30-79%) |
| HP:0002094 | Dyspnea | Frequent (30-79%) |
| HP:0012378 | Fatigue | Frequent (30-79%) |
| HP:0025168 | Left ventricular diastolic dysfunction | Frequent (30-79%) |
| HP:0031331 | Abnormal cardiomyocyte morphology | Frequent (30-79%) |
| HP:0100749 | Chest pain | Frequent (30-79%) |
| HP:0001653 | Mitral regurgitation | Occasional (5-29%) |
| HP:0001685 | Myocardial fibrosis | Occasional (5-29%) |
| HP:0006685 | Endocardial fibrosis | Occasional (5-29%) |
| HP:0010872 | T-wave inversion | Occasional (5-29%) |
| HP:0011675 | Arrhythmia | Occasional (5-29%) |
| HP:0011712 | Right bundle branch block | Occasional (5-29%) |
| HP:0012735 | Cough | Occasional (5-29%) |
| HP:0025523 | Abnormal morphology of the chordae tendinae of the mitral valve | Occasional (5-29%) |
| HP:0031295 | Left atrial enlargement | Occasional (5-29%) |
| HP:0031442 | Abnormal tricuspid chordae tendinae morphology | Occasional (5-29%) |
| HP:0001650 | Aortic valve stenosis | Very rare (<1-4%) |
| HP:0001659 | Aortic regurgitation | Very rare (<1-4%) |
| HP:0001701 | Pericarditis | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Loeffler endocarditis |
| Mondo ID | MONDO:0019159 |
| Orphanet | 75566 |
| DOID | DOID:396 |
| ICD-11 | 1223390562 |
| NCIT | C27044 |
| SNOMED CT | 449829009 |
| UMLS | C0206143 |
| MedGen | 104788 |
| GARD | 0018929 |
| MedDRA | 10052841 |
| Is cancer (heuristic) | no |
Also known as: eosinophilic endocarditis · eosinophilic endomyocardial disease
Disease family
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › muscle tissue disorder › cardiomyopathy › intrinsic cardiomyopathy › restrictive cardiomyopathy › non-familial restrictive cardiomyopathy › Loeffler endocarditis
Related subtypes (6): cardiac sarcoidosis, hypereosinophilic syndrome, wild type ATTR amyloidosis, tropical endomyocardial fibrosis, AL amyloidosis, AA amyloidosis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.